Background The treatment of cardiogenic shock with percutaneous mechanical circulatory
support (MCS) is attractive: however, at present it is not clear which is the best strategy, as …

Objective The contribution of cardiogenic shock to in-hospital mortality has not decreased
significantly despite prompt revascularization, advances in medical therapy, and mechanical …

Introduction Cardiogenic shock (CS) is a life-threatening condition and mechanical
circulatory support (MCS) might exert a relevant impact on its clinical course. Among MCS …

Background Acute cardiogenic shock is associated with high mortality rates. Mechanical
circulatory devices have been increasingly used in this setting for hemodynamic support …

Background With the rapid development of mechanical circulatory support technologies,
patients presenting with cardiogenic shock have gained access to various treatment …

Introduction: The clinical impact of invasive hemodynamic support with Impella in patients
with cardiogenic shock (CS) remains to be defined. Methods: Only studies including patients …

The number of patients treated with the mechanical circulatory support device Impella
Cardiac Power (CP) for cardiogenic shock is steadily increasing. The aim of this study was to …

BACKGROUND The Impella pump has emerged as a promising tool in patients with
cardiogenic shock (CS). Despite its attractive properties, there are scarce data on the …

Background: Percutaneous mechanical circulatory support devices are increasingly used in
acute myocardial infarction complicated by cardiogenic shock (AMI-CS), despite limited …

Rationale Short-term mechanical circulatory support is increasingly used in the
management of cardiogenic shock, but data from controlled studies are sparse. Thus, real …